TickerFactsScreenerDevelopers

TANDEM DIABETES CARE INC (TNDM) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2012: $3.82M2013: $22.84M2014: $34.47M2015: $46.27M2016: $60.66M2017: $63.51M2018: $94.04M2019: $168.09M2020: $238.31M2021: $326.58M2022: $388.23M2023: $380.03M2024: $450.63M2025: $468.72M$468.72M
2012Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$468.72M+4.0%
2024$450.63M+18.6%
2023$380.03M-2.1%
2022$388.23M+18.9%
2021$326.58M+37.0%
2020$238.31M+41.8%
2019$168.09M+78.7%
2018$94.04M+48.1%
2017$63.51M+4.7%
2016$60.66M+31.1%
2015$46.27M+34.2%
2014$34.47M+50.9%
2013$22.84M+497.4%
2012$3.82M—